Vanda Pharmaceuticals (VNDA) Financials: Revenue & Earnings

VNDA price $3.85 -0.14 -3.51%

Ticker
VNDA
Price
$3.85
Change
-0.14 -3.51%
Market cap ?
$232.78M
Beta ?
0.69
Sector
Healthcare
Industry
Biotechnology

Fair value

VNDA fair value $16.91. Price $3.85. Price is 77% below fair value.

Below fair value, and cheaper than usual. A larger discount than on more than 99% of days in the past 5 years.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Calculated with a 10-year free-cash-flow discount. Starting free cash flow 42.74M. Growth 15.16%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 8.70% (beta 0.8). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 60.46M. Net debt -72.23M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the stock's own 10-year median P/E, kept between 8 and 40. Fewer than five years of history uses the sector's typical P/E. Fair value is the average of the cash-flow value and the earnings value when both exist. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.

Model uncertainty high for this stock

Compare VNDA

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-10-28—-0.68—69.20M
2026-08-05-1.04-0.5850.53M61.92M
2026-05-06-0.82-0.5351.72M54.98M
2026-02-11-2.39-2.1857.22M59.27M
2025-10-29-0.38-0.3156.26M59.27M
2025-07-31-0.46-0.3452.59M58.73M
2025-05-07-0.50-0.5550.04M45.13M
2025-02-13-0.08-0.1453.19M52.25M
2024-11-06-0.09-0.1747.65M49.15M
2024-07-31-0.08-0.2150.47M50.73M
2024-05-08-0.070.0547.46M48.50M
2024-02-07-0.04-0.0945.27M37.00M
2023-11-080.000.0038.81M44.50M
2023-07-270.03-0.1346.06M50.50M
2023-05-030.06—62.50M—
2023-02-080.120.0864.48M67.60M
2022-11-020.060.0965.32M71.00M
2022-08-030.050.1164.39M67.00M
2022-05-05-0.11-0.0160.19M58.00M
2022-02-230.120.0968.02M70.04M
2021-11-030.140.1870.09M75.00M
2021-07-280.170.1467.90M75.00M
2021-05-050.150.1562.67M68.50M
2021-02-100.150.1467.65M62.82M
2020-10-280.110.1060.31M163.43M
2020-08-050.160.0462.21M15.55M
2020-05-060.010.0058.00M—
2020-02-250.080.1160.93M83.78M
2019-11-061.840.0759.48M2.26M
2019-07-310.210.0059.06M—
2019-05-010.060.0647.71M333.99M
2019-02-130.190.1353.04M2.79M
2018-11-070.200.0349.13M11.34M
2018-08-010.140.0647.35M94.70M
2018-05-020.14-0.0543.59M123.51M
2018-02-14-0.04-0.1244.28M132.83M
2017-11-07-0.10-0.1041.34M45.47M
2017-08-02-0.03-0.2142.06M392.52M
2017-05-02-0.17-0.1337.41M41.82M
2017-02-15-0.01-0.0938.24M344.20M

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-06-04McGuire Daniel PatrickBuy80.00K——
2026-06-04Chrousos PhaedraBuy41.60K——
2026-06-04Duncan Charles CliffBuy41.60K——
2026-06-04DUGAN RICHARD WBuy41.60K——
2026-06-04Ward Anne SempowskiBuy41.60K——
2026-06-04Honore TageBuy41.60K——
2026-06-04Mitchell Stephen RayBuy41.60K——
2026-06-04McGuire Daniel PatrickOther0——
2026-06-04McGuire Daniel PatrickOther0——
2026-06-04McGuire Daniel PatrickOther0——
2026-06-04McGuire Daniel PatrickOther0——
2026-05-18Mitchell Stephen RaySell25.84K——
2026-04-22Duncan Charles CliffBuy57.10K——
2026-04-22Duncan Charles CliffOther0——
2026-04-01Polymeropoulos Christos Vasilios MihaelOther0——
2026-04-01Polymeropoulos Christos Vasilios MihaelOther0——
2026-04-01Polymeropoulos Christos Vasilios MihaelOther0——
2026-04-01Polymeropoulos Christos Vasilios MihaelOther0——
2026-04-01Polymeropoulos Christos Vasilios MihaelOther0——
2026-04-01Polymeropoulos Christos Vasilios MihaelOther61.20K$7.05431.46K
2026-04-01Howell Scott LaverneOther0——
2026-04-01Howell Scott LaverneOther0——
2026-04-01Howell Scott LaverneOther0——
2026-04-01Howell Scott LaverneOther0——
2026-04-01Howell Scott LaverneOther0——
2026-04-01Howell Scott LaverneOther0——
2026-04-01Howell Scott LaverneOther77.50K$7.05546.38K
2026-04-01Howell Scott LaverneOther61.20K$11.36695.23K
2026-04-01Howell Scott LaverneOther28.60K$20.28580.01K
2026-04-01Howell Scott LaverneOther25.00K$11.32283.00K
2026-03-02Williams TimothySell42.43K$8.27350.76K
2026-03-02Moran Kevin PatrickSell42.44K$8.27350.82K
2026-03-02Wijkstrom JoakimSell30.80K$8.27254.59K
2026-03-02Polymeropoulos Mihael HristosSell156.24K$8.171.28M
2026-03-02Birznieks GuntherSell42.43K$8.27350.73K
2026-02-23Honore TageSell30.00K$8.03240.90K
2026-02-18Wijkstrom JoakimBuy125.00K——
2026-02-18Birznieks GuntherBuy125.00K——
2026-02-18Williams TimothyBuy125.00K——
2026-02-18Moran Kevin PatrickBuy125.00K——
2026-02-18Polymeropoulos Mihael HristosBuy525.00K——
2025-08-07Polymeropoulos Mihael HristosBuy10.00K$4.1541.50K
2025-06-13Mitchell Stephen RaySell7.00K$4.5932.13K
2025-06-05Mitchell Stephen RayBuy59.23K——
2025-06-05Chrousos PhaedraBuy59.23K——
2025-06-05DUGAN RICHARD WBuy59.23K——
2025-06-05Honore TageBuy59.23K——
2025-06-05Ward Anne SempowskiBuy59.23K——
2025-05-21Polymeropoulos Mihael HristosBuy481$4.392.11K
2025-05-21Polymeropoulos Mihael HristosBuy9.52K$4.4041.88K
2025-05-16Polymeropoulos Mihael HristosBuy20.00K$4.2284.47K
2025-03-06Polymeropoulos Mihael HristosBuy5.00K$5.0125.05K
2025-03-06Polymeropoulos Mihael HristosBuy5.00K$5.0225.10K
2025-03-05Polymeropoulos Mihael HristosBuy5.00K$5.0325.15K
2025-03-05Polymeropoulos Mihael HristosBuy5.00K$5.0125.05K
2025-03-03Polymeropoulos Mihael HristosBuy10.00K$4.7147.05K
2025-03-01Wijkstrom JoakimSell15.52K$4.7673.88K
2025-03-01Birznieks GuntherSell26.94K$4.76128.24K
2025-03-01Polymeropoulos Mihael HristosSell96.00K$4.76456.96K
2025-03-01Moran Kevin PatrickSell26.94K$4.76128.24K
2025-03-01Williams TimothySell26.94K$4.76128.24K
2025-02-28Polymeropoulos Mihael HristosBuy10.00K$4.7647.60K
2025-02-27Polymeropoulos Mihael HristosBuy10.00K$4.7647.60K
2025-02-26Polymeropoulos Mihael HristosBuy5.00K$4.7823.90K
2025-02-26Polymeropoulos Mihael HristosBuy5.00K$4.7523.75K
2025-02-25Polymeropoulos Mihael HristosBuy10.00K$4.4644.64K
2025-02-21Moran Kevin PatrickBuy2.00K$4.398.78K
2025-02-18Wijkstrom JoakimBuy125.00K——
2025-02-18Polymeropoulos Mihael HristosBuy450.00K——
2025-02-18Moran Kevin PatrickBuy125.00K——
2025-02-18Birznieks GuntherBuy125.00K——
2025-02-18Williams TimothyBuy125.00K——
2024-11-14Mitchell Stephen RaySell5.00K$5.1725.86K
2024-07-29Moran Kevin PatrickSell2.25K$5.9213.33K
2024-05-22Chrousos PhaedraBuy21.89K——
2024-05-22Chrousos PhaedraBuy40.20K$5.14206.64K
2024-05-17Honore TageBuy20.53K——
2024-05-17Honore TageBuy37.58K$5.48205.93K
2024-05-17DUGAN RICHARD WBuy20.53K——
2024-05-17DUGAN RICHARD WBuy37.58K$5.48205.93K
2024-05-17Mitchell Stephen RayBuy20.53K——
2024-05-17Mitchell Stephen RayBuy37.58K$5.48205.93K
2024-05-17Ward Anne SempowskiBuy20.53K——
2024-05-17Ward Anne SempowskiBuy37.58K$5.48205.93K
2024-03-05Williams TimothySell8.94K$4.1837.40K
2024-03-05Wijkstrom JoakimSell9.23K$4.2138.83K
2024-03-05Polymeropoulos Mihael HristosSell24.29K$4.13100.27K
2024-03-05Moran Kevin PatrickSell8.90K$4.2037.41K
2024-03-05Birznieks GuntherSell8.68K$4.1335.88K
2024-03-04Williams TimothySell8.15K$4.4135.92K
2024-03-04Wijkstrom JoakimSell7.50K$4.4133.09K
2024-03-04Polymeropoulos Mihael HristosSell30.88K$4.24131.07K
2024-03-04Moran Kevin PatrickSell5.80K$4.4825.98K
2024-03-04Birznieks GuntherSell8.73K$4.3037.49K
2024-02-16Williams TimothyBuy125.00K——
2024-02-16Wijkstrom JoakimBuy32.70K——
2024-02-16Moran Kevin PatrickBuy125.00K——
2024-02-16Polymeropoulos Mihael HristosBuy450.00K——
2024-02-16Birznieks GuntherBuy125.00K——
2023-08-21Wijkstrom JoakimSell3.72K$5.8421.75K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 177, holders +2 vs prior quarter. Ownership 83.57%.

HolderSharesChangeChange %Value
BLACKROCK, INC.7.65M377.75K+5.19%46.84M
STATE STREET CORP3.52M500.84K+16.61%21.52M
AQR CAPITAL MANAGEMENT LLC3.50M1.89M+118.12%21.41M
RENAISSANCE TECHNOLOGIES LLC3.44M-318.20K-8.46%21.06M
VANGUARD CAPITAL MANAGEMENT LLC2.52M42.55K+1.71%15.45M
AIGH CAPITAL MANAGEMENT LLC2.04M-705.83K-25.67%12.51M
ACADIAN ASSET MANAGEMENT LLC1.92M122.47K+6.82%11.73M
DIMENSIONAL FUND ADVISORS LP1.73M-44.24K-2.50%10.57M
MILLENNIUM MANAGEMENT LLC1.60M-278.19K-14.79%9.81M
GEODE CAPITAL MANAGEMENT, LLC1.48M40.82K+2.83%9.08M
TWO SIGMA INVESTMENTS, LP1.35M-49.13K-3.51%8.26M
MARSHALL WACE, LLP1.23M629.99K+105.70%7.50M
JACOBS LEVY EQUITY MANAGEMENT, INC1.21M44.65K+3.82%7.43M
KRENSAVAGE ASSET MANAGEMENT, LLC1.18M00.00%7.22M
VANGUARD PORTFOLIO MANAGEMENT LLC1.13M116.51K+11.48%6.92M
GOLDMAN SACHS GROUP INC1.04M198.03K+23.62%6.34M
CITADEL ADVISORS LLC758.30K697.80K+1153.39%4.64M
QUBE RESEARCH & TECHNOLOGIES LTD729.21K729.21KNew4.46M
FEDERATED HERMES, INC.714.28K138.89K+24.14%4.37M
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P.646.26K646.26KNew3.96M
CHARLES SCHWAB INVESTMENT MANAGEMENT INC646.26K94.49K+17.12%3.96M
NORTHERN TRUST CORP600.62K149.64K+33.18%3.68M
MORGAN STANLEY477.97K37.18K+8.43%2.93M
LIONHUNTER CAPITAL MANAGEMENT, LLC400.25K400.25KNew2.45M
VANGUARD FIDUCIARY TRUST CO399.82K11.85K+3.06%2.45M

Earnings and financials

Vanda Pharmaceuticals Inc. (VNDA) trades at $3.85, with a market cap of $232.78M and a trailing P/E of n/a. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Vanda Pharmaceuticals (VNDA) Financials: Revenue & Earnings

VNDA$3.85-0.14 -3.51%

$232.78M

Market Cap

—

P/E

—

Forward P/E

—

Score

Price History